Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Hamas Calls for West Bank ‘Day of Rage’

In spite of the ceasefire between Israel and Hamas, the terror…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Google Hit with Lawsuit over Data Collection

Googles is facing a lawsuit after they continued to collect…
Read more

UK Wants G7 to Agree on Vaccine Passports

Prime Minister Boris Johnson is looking for G7 to agree regarding…
Read more